Atlas Trials

The INTEGRATE Study: Integrated Pharmacogenetics, TDM and Active Pharmacovigilance as Innovative Tools for the Optimisation and Appropriateness of Drug Therapy

Clinical trial NCT06822959 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06822959
Sponsor
Direzione centrale salute, politiche sociali e disabilità
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Adverse Drug Reaction (ADR)
Start date
2022-06-10
Primary completion
2025-12-31
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.